Both in Pharmaceuticals
Turn Therapeutics vs Fulcrum Therapeutics
Over the past year TTRX returned +126.6% and FULC returned −55.0%; their daily moves had a correlation of -0.10.
TTRX +126.6% FULC −55.0%Growth of $1, one year, split-adjusted
| Metric | TTRX | FULC |
|---|---|---|
| Price | $9.80 | $3.77 |
| Market cap | $297.6M | $288.0M |
| Today | +3.05% | +0.80% |
| 1 month | −15.8% | +2.2% |
| 6 months | +158.2% | −47.0% |
| Year to date | +148.7% | −66.7% |
| 1 year | +121.7% | −58.2% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $4.2M | $318.8M |
| Dividend yield | — | — |
| Volatility (60d) | 89.4% | 15.0% |
| Short % of float | 3.0% | 10.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).